Stock Events

Coherus Biosciences (CHRS) Q4 2022 Earnings

6MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1
-0.82
-0.65
-0.47

Details

Expected EPS
-0.84
Actual EPS
-0.6
Surprise EPS
0.24
Surprise Percent
+28.57%

Description

Coherus Biosciences (CHRS) has reported earnings of -0.6 per share for Q4 2022.

0 Comments

Share your thoughts